Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 1861-1880 of 2,724 trials

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

NCT00597818

The primary purpose of this study is to determine the efficacy and safety of three dose levels of cobiprostone as compared to placebo in OA/RA patients treated with an NSAID for 20 months.

NSAID-induced Gastroduodenal InjuryUlcersRheumatoid Arthritis+1 more

Sucampo Pharma Americas, LLC121 participantsStarted Aug 2007

Phoenix, Arizona, United States • Chula Vista, California, United States • Loma Linda, California, United States +16 more locations

COMPLETEDNA< 1 mile

EverFlex Post Approval Study

NCT01680835

This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal arteries.

Peripheral Arterial DiseaseLower Extremity Arterial Disease

Medtronic Endovascular108 participantsStarted Jan 2013

Phoenix, Arizona, United States • Modesto, California, United States • Sacramento, California, United States +20 more locations

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

EverFlex Post Approval Study

Rheumatoid Arthritis Trials in Other Cities

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Evaluating the Acute Glycemic Response to Different Strategies of Breaking Up Sedentary Time

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ImageReady(TM) MR Conditional Pacing System Clinical Study

Post Market Surveillance Study of the Wingspan Stent System

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

SPRINT - Randomized Trial of Tibial Fracture Fixation

A Clinical Trial of IntensiVE Dialysis

A Study of Factors That Affect Long-Term Kidney Transplant Function

Other Conditions in Phoenix